| Patient-derived organoids from multiple colorectal cancer liver metastases reveal moderate intra-patient pharmacotranscriptomic heterogeneity J Bruun, K Kryeziu, PW Eide, SH Moosavi, IA Eilertsen, J Langerud, ... Clinical Cancer Research 26 (15), 4107-4119, 2020 | 75 | 2020 |
| Metastatic heterogeneity of the consensus molecular subtypes of colorectal cancer PW Eide, SH Moosavi, IA Eilertsen, TH Brunsell, J Langerud, KCG Berg, ... NPJ genomic medicine 6 (1), 59, 2021 | 39 | 2021 |
| Technical differences between sequencing and microarray platforms impact transcriptomic subtyping of colorectal cancer IA Eilertsen, SH Moosavi, JM Strømme, A Nesbakken, B Johannessen, ... Cancer letters 469, 246-255, 2020 | 18 | 2020 |
| De novo transcriptomic subtyping of colorectal cancer liver metastases in the context of tumor heterogeneity SH Moosavi, PW Eide, IA Eilertsen, TH Brunsell, KCG Berg, BI Røsok, ... Genome Medicine 13, 1-19, 2021 | 14 | 2021 |
| Spatial analysis and CD25-expression identify regulatory T cells as predictors of a poor prognosis in colorectal cancer CH Bergsland, M Jeanmougin, SH Moosavi, A Svindland, J Bruun, ... Modern Pathology 35 (9), 1236-1246, 2022 | 11 | 2022 |
| Increased sensitivity to SMAC mimetic LCL161 identified by longitudinal ex vivo pharmacogenomics of recurrent, KRAS mutated rectal cancer liver metastases K Kryeziu, SH Moosavi, CH Bergsland, MG Guren, PW Eide, MZ Totland, ... Journal of Translational Medicine 19, 1-11, 2021 | 7 | 2021 |
| Mutation detection in activin A receptor, Type I (ACVR1) gene in fibrodysplasia ossificans progressiva in an Iranian family Z Morovvati, S Morovvati, GA Alishiri, SH Moosavi, R Ranjbar, ... Cell Journal (Yakhteh) 16 (1), 91, 2014 | 3 | 2014 |
| Multiregional transcriptomics of colorectal cancers define prognostic features less vulnerable to tumor heterogeneity J Langerud, IA Eilertsen, H Moosavi, IF Backe, M Hektoen, M Jeanmougin, ... Cancer Research 83 (7_Supplement), 4540-4540, 2023 | | 2023 |
